Pharmaids Pharmaceuticals Ltd

Pharmaids-Pharmaceuticals-Ltd06 Dec 2024

Pharmaceuticals

₹

-3.03 (-4.99%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Pharmaids Pharmaceuticals Ltd

Pharmaids Pharmaceuticals Ltd

Pharmaceuticals

Pharmaids-Pharmaceuticals-Ltd06 Dec 2024

₹

-3.03 (-4.99%)

OverviewFundamentals

Corporate action

Peer comparison

Cash flow

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
03-Dec-2024	BC	Shreedhara Shetty (Sale Dated on: 02/12/2024 & 03/12/2024)	02-Dec-2024
02-Dec-2024	BC	Shreedhara Shetty (Sale Dated on: 27/11/2024 to 29/11/2024)	27-Nov-2024
28-Nov-2024	BC	Shreedhara Shetty (Sale Dated on: 25/11/2024 & 27/11/2024)	25-Nov-2024
07-Nov-2024	BC	PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve the unaudited financial results	13-Nov-2024
28-Aug-2024	BC	The Board decided to convene the 35th Annual General Meeting of the Company on Wednesday, September 25, 2024, at 11:30 A.M. through Video Conferencing (VC) / Other Audio Visual Means ('OAVM'), in com	25-Sep-2024

No Rights has been declared by Pharmaids-Pharmaceuticals-Ltd

Book Closure

Record Date	Split Date	Purpose
02-Dec-2024	-	Shreedhara Shetty (Sale Dated on: 02/12/2024 & 03/12/2024)
27-Nov-2024	-	Shreedhara Shetty (Sale Dated on: 27/11/2024 to 29/11/2024)
25-Nov-2024	-	Shreedhara Shetty (Sale Dated on: 25/11/2024 & 27/11/2024)
13-Nov-2024	-	PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve the unaudited financial results
25-Sep-2024	-	The Board decided to convene the 35th Annual General Meeting of the Company on Wednesday, September 25, 2024, at 11:30 A.M. through Video Conferencing (VC) / Other Audio Visual Means ('OAVM'), in com

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Pharmaids Pharmaceuticals Ltd ₹57.67(-3.03/-4.99%)	57.67	-3.03	214.08	51.75	0.00	3.13
Ambalal Sarabhai Enterprises Ltd ₹58.60(+0.61/1.05%)	58.60	+0.61	444.40	44.98	50.43	9.86
Astrazeneca Pharma India Ltd ₹6,659.55(+29.00/0.44%)	6,659.55	+29.00	16,576.38	37.17	128.77	24.40
Abbott India Ltd ₹29,237.00(+213.25/0.73%)	29,237.00	+213.25	61,675.47	25.54	48.01	17.52
Amrutanjan Health Care Ltd ₹728.95(-9.05/-1.23%)	728.95	-9.05	2,133.60	23.31	44.89	7.16
Bliss GVS Pharma Ltd ₹160.20(-0.60/-0.37%)	160.20	-0.60	1,693.74	12.68	20.96	1.65

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Cash and Cash Equivalents at Beginning of the year	12.75	0.41	0.20	0.02	0.11
Net Cash from Operating Activities	-3.44	-4.02	-0.26	0.41	-0.75
Net Cash Used In Investing Activities	-72.51	-4.95	0.47	-0.23	0.66
Net Cash Used In Financing Activities	65.66	21.31	0.00	0.00	0.00
Net Inc./Dec In Cash And Cash Equivalents	-10.29	12.35	0.21	0.18	-0.09
Cash And Cash Equivalents At End Of The Year	2.46	12.75	0.41	0.20	0.02

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

5.19%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

94.81%

**Promoter pledged shareholding 5.19%

About Pharmaids Pharmaceuticals Ltd

Pharmaids Pharmaceuticals Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 214.08 crores. It has reported a sales of Rs. 0.83 crores and a net profit of Rs. -1.01 crores for the quarter ended December 2018. The company management includes Shankarappa Nagaraja Vinaya Babu, Venu Madhava Kaparthy,Mini Manikantan,Sadhanala Venkata Rao,P N Vijay,M Sudheer Anand,Methuku Nagesh,Shreedhara Shetty,Shankarappa Nagaraja Vinaya Babu (Pharmaids Pharmaceuticals Ltd) among others.

Chairman

Shankarappa Nagaraja Vinaya Babu

Registered office

4-4-211/212/3 1st Floor,Inderbagh Sulthan Bazar,Hyderabad,Telangana,500095

FAX :91-40-23232348

Background

Incorporation Year1989

Face Value₹10

Market Lot1